If you need more lookups,
subscriptions start at $34 USD/month.
Kees Lucas Location
Amsterdam, NH, NL
Kees Lucas Work
2019 -now BD Consultant @
2018 -now Member of the Board of Directors @
2005 -now Owner and managing director @
2014 -now Chairman of the Board @
2016 -now Board of Directors Member @ CVasThera
2004 -now buss associate @ inventages business partner
2004 -2014 Senior Partner @ parteurop
2007 -2012 Non Executive Director @ CMP pharmaceuticals
2005 -2011 director BD @ imaxio
2005 -2011 partner @ van rooijen en partners
2009 -2010 buss development cons @ GLYCODE
2005 -2008 Non Executive Director @ Theraptosis
2006 -2007 Director Business development @
2006 -2007 senior partner @ Bionest Partners
2005 -2007 non executive boardmember @
2000 -2005 Senior Director Corporate Development @
2000 -2001 consultant @
1990 -1999 director @ TNO Prevention and Health
1968 -1989 Div head @ Sanquin, clb
Kees Lucas Skills
Biotechnology
Biopharmaceuticals
Technology Transfer
Pharmaceutical Industry
Commercialization
Vaccines
Clinical Development
Drug Development
Regulatory Affairs
Venture Capital
Oncology
Immunology
Lifesciences
CRO
Market Access
R&D
Drug Discovery
Medical Devices
Clinical Trials
Infectious Diseases
Health Economics
Regulatory Submissions
Biomarkers
Hardware Diagnostics
Pharmaceutics
Genomics
Biochemistry
Biologics
Mergers & Acquisitions
Corporate Development
Strategy
Life Sciences
Social Media
Sales
Business Analysis
Management
Mergers and Acquisitions
Business Development
Project Management
Business Strategy
Microsoft Excel
Microsoft Office
Research
Marketing
Kees Lucas Summary
Kees Lucas, based in Amsterdam, NH, NL, is currently a BD Consultant at Regulaxis SAS. Kees Lucas brings experience from previous roles at OP2 Drugs SAS ("OP2"), Life Science Consultancy, Biotecnol, Inc and CVasThera. With a robust skill set that includes Biotechnology, Biopharmaceuticals, Technology Transfer, Pharmaceutical Industry, Commercialization and more.
Looking for a different Kees Lucas?
Find contact details for 700 million professionals.